Extracellular sphingomyelinase induces interleukin-6 synthesis in osteoblasts

Area of Science:

• Biochemistry
• Cell Biology
• Osteology

Background:

• Sphingomyelin metabolites, like sphingosine 1-phosphate, are implicated as second messengers in cellular signaling.
• Tumor necrosis factor-alpha (TNF) induces interleukin-6 (IL-6) synthesis in osteoblast-like cells via these metabolites.

Purpose of the Study:

• To investigate the role of extracellular sphingomyelinase in regulating IL-6 synthesis in MC3T3-E1 osteoblast-like cells.
• To elucidate the signaling pathways involved in sphingomyelinase-induced IL-6 production.

Main Methods:

• MC3T3-E1 cells were treated with extracellular sphingomyelinase.
• IL-6 synthesis was measured over time and with varying enzyme concentrations.
• Inhibitors of protein kinase C (Calphostin C) and sphingosine kinase (DL-Threo-dihydrosphingosine) were used.
• Sphingomyelin hydrolysis was assessed.

Main Results:

• Sphingomyelinase dose-dependently and time-dependently stimulated IL-6 synthesis.
• Protein kinase C inhibition enhanced sphingomyelinase-induced IL-6 production, while sphingosine kinase inhibition suppressed it.
• Sphingomyelinase treatment led to significant sphingomyelin hydrolysis.
• Combined sphingomyelinase and TNF treatment showed synergistic effects on IL-6 synthesis.

Conclusions:

• Extracellular sphingomyelinase induces IL-6 synthesis in osteoblasts through sphingomyelin hydrolysis.
• Protein kinase C acts as a negative regulator of IL-6 synthesis in this pathway.
• This study reveals a novel signaling mechanism involving sphingomyelinase in osteoblast function.